WT1 and acute myeloid leukemia: Given all these criteria, the objective was to train machine learning methods for the identification of TCRs recognizing either the WT1-37 or the WT1-126 peptide and to investigate the ability of trained machine learning methods to identify new WT1-specific TCR β sequences in the repertoires of patients with AML.